W. Noack, M. Fischer, K. Fö-rster, L. Rovati, and I. Setnikar, Glucosamine sulfate in osteoarthritis of the knee, Osteoarthritis and Cartilage, vol.2, issue.1, pp.51-60, 1994.
DOI : 10.1016/S1063-4584(05)80006-8

H. Mü-ller-fassbender, G. Bach, W. Haase, L. Rovati, and I. Setnikar, Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee, Osteoarthritis and Cartilage, vol.2, issue.1, pp.61-70, 1994.
DOI : 10.1016/S1063-4584(05)80007-X

L. Rovati, G. Giacovelli, M. Annefeld, L. Dreiser, and B. Avouac, A large randomised, placebo controlled, doubleblind study of glucosamine sulfate vs. piroxicam and Table II Effect of glucosamine sulfate (GS) on nitric oxide (NO), cyclic adenosine monophosphate (cAMP) and protein kinase C (PKC) activity (binding of 3 H-PDBU) of human osteoarthritic chondrocytes in culture GS (M)

M. Piperno, Glucosamine sulfate and chondrocytes vs. their association, on the kinetics of the symptomatic effect in knee osteoarthritis, Osteoarthritis and Cartilage, vol.2, issue.1, p.56, 1994.

R. Altman, Design and conduct of clinical trials in patients with osteoarthritis: Recommendations from a task force of the Osteoarthritis Research Society, Osteoarthritis and Cartilage, vol.4, issue.4, pp.217-260, 1996.
DOI : 10.1016/S1063-4584(05)80101-3

M. Dougados, For the Group for the Respect of Ethics and Excellence in Science. Recommendations for the registration of drugs used in the treatment of osteoarthritis, Ann Rheum Dis, vol.55, pp.552-559, 1996.

J. Reginster, R. Decroix, and I. Paul, Glucosamine sulfate significantly reduces progression of knee osteoarthritis over 3 years: a large randomized, placebo-controlled double blind prospective trial, Arthritis Rheum, 1999.

I. Senitkar, R. Cereda, M. Pacini, and L. Revel, Antireactive properties of glucosamine sulfate, Arzneim-Forsch, vol.41, pp.157-61, 1991.

A. Maroudas, Balance between swelling pressure and collagen tension in normal and degenerate cartilage, Nature, vol.51, issue.5554, pp.808-817, 1976.
DOI : 10.1016/0304-4165(69)90311-0

D. Dean, Proteinase-mediated cartilage degradation in osteoarthritis, Seminars in Arthritis and Rheumatism, vol.20, issue.6, pp.2-11, 1991.
DOI : 10.1016/0049-0172(91)90023-S

J. Pelletier, F. Mineau, M. Faure, and J. Martel-pelletier, Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritis, Arthritis & Rheumatism, vol.20, issue.10, pp.1466-76, 1990.
DOI : 10.1016/0304-4165(84)90412-4

K. Tsuchiya, W. Maloney, T. Vu, A. Hoffman, P. Hule et al., Osteoarthritis: Differential expression of matrix metalloproteinase-9 mRNA in nonfibrillated and fibrillated cartilage, Journal of Orthopaedic Research, vol.20, issue.1, pp.94-100, 1997.
DOI : 10.1042/bj2590061

H. Mankin, H. Dorfman, L. Lippiello, and A. Zarins, Biochemical and Metabolic Abnormalities in Articular Cartilage from Osteo-Arthritic Human Hips, The Journal of Bone & Joint Surgery, vol.53, issue.3, pp.523-530, 1971.
DOI : 10.2106/00004623-197153030-00009

T. Algner, S. Vornehm, G. Zeidler, J. Dudhia, V. Der-mark et al., Suppression of cartilage matrix gene expression in upper zone chondrocytes of osteoarthritic cartilage, Arthritis & Rheumatism, vol.14, issue.3, pp.562-571, 1997.
DOI : 10.1016/S0934-8832(11)80205-2

M. Pelletier, J. Mccollum, R. Dibattista, J. Faure, M. Chin et al., The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes. Identification as the type I receptor and analysis of binding kinetics and biologic function, Arthritis & Rheumatism, vol.82, issue.5, pp.530-570, 1992.
DOI : 10.1002/art.1780350507

C. Westacott, R. Atkins, P. Dieppe, and C. Elson, Tumor necrosis factor-? receptor expression on chondrocytes isolated from human articular cartilage, J Rheumatol, vol.21, pp.1710-1715, 1994.

E. Vignon, P. Mathieu, P. Louisot, J. Vilamitjana, M. Harmand et al., Phospholipase A2 activity in human osteoarthritic cartilage, J Rheumatol, vol.16, issue.18, pp.35-43, 1989.

A. Amin, D. Cesare, P. Vyas, P. Attur, M. Tzeng et al., The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: evidence for up-regulated neuronal nitric oxide synthase, Journal of Experimental Medicine, vol.182, issue.6, pp.2097-102, 1995.
DOI : 10.1084/jem.182.6.2097

J. Pelletier, F. Mineau, P. Ranger, G. Tardif, and J. Martel-pelletier, The increased synthesis of inducible nitric oxide inhibits IL-1ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation, Osteoarthritis and Cartilage, vol.4, issue.1, pp.77-84, 1996.
DOI : 10.1016/S1063-4584(96)80009-4

Y. Vidal, R. Plana, D. Bizzarri, and A. Rovati, Articular cartilage pharmacology: I. In vitro studies on glucosamine and non steroidal antiinflammatory drugs, Pharmacological Research Communications, vol.10, issue.6, pp.557-69, 1978.
DOI : 10.1016/S0031-6989(78)80054-X

C. Bassleer, L. Rovati, and P. Franchimont, Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro, Osteoarthritis and Cartilage, vol.6, issue.6, pp.427-461, 1998.
DOI : 10.1053/joca.1998.0146

S. Jimenez and G. Dodge, The effects of Glucosamine Sulfate (GSO 4 ) on human chondrocyte gene expression, Osteoarthritis and Cartilage, vol.5, p.72, 1997.

M. Hellio, M. Peschard, C. Cohen, M. Richard, and E. Vignon, Calcitonin inhibits phospholipase A2 and collagenase activity of human osteoarthritic chondrocytes, Osteoarthritis and Cartilage, vol.5, issue.2, pp.121-129, 1997.
DOI : 10.1016/S1063-4584(97)80005-2

P. Smith, R. Krohn, G. Hermanson, A. Mallia, F. Gartner et al., Measurement of protein using bicinchoninic acid, Analytical Biochemistry, vol.150, issue.1, pp.76-85, 1985.
DOI : 10.1016/0003-2697(85)90442-7

E. Vignon, P. Mathieu, P. Louisot, and M. Richard, In Vitro Effect of Nonsteroidal Antiinflammatory Drugs on Proteoglycanase and Collagenase Activity in Human Osteoarthritic Cartilage, Arthritis & Rheumatism, vol.32, issue.10, pp.1332-1337, 1991.
DOI : 10.1042/bj2480265

Y. Hannun, C. Loomis, A. Merrill, and R. Bell, Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets, J Biol Chem, vol.261, pp.1260-1269, 1986.

A. Steiner, A. Pagliara, L. Chase, and D. Kipnis, Radioimmunoassay for cyclic nucleotides: adenosine 3? 5? monophosphate and guanosine 3? 5? monophosphate in mammalian tissues and body fluids, J Biol Chem, vol.247, pp.1114-1134, 1972.

J. Harper and G. Brooker, Fentomole sensitive radioimmunoassay for cyclic AMP and GM2 after 2-O- acetylation by acetic anhydride in aqueous solution

E. Vignon, P. Mathieu, J. Bejui, J. Descotes, D. Hartmann et al., Study of an inhibitor of plasminogen activator (tranexamic acid) in the treatment of experimental osteoarthritis, J Rheumatol, vol.27, pp.131-134, 1991.

L. Yu, G. Smith, K. Brandt, S. Myers, O. Connor et al., Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline, Arthritis & Rheumatism, vol.32, issue.10, pp.1150-1159, 1992.
DOI : 10.1042/bst0180812

W. Pruzanski, E. Bogoch, A. Katz, M. Wloch, E. Stefanski et al., Induction of release of secretory nonpancreatic phospholipase A2 from human articular chondrocytes, J Rheumatol, vol.22, pp.2114-2123, 1995.

P. Kortekangas, H. Aro, and T. Nevalainen, Group II Phospholipase A2 in Synovial Fluid and Serum in Acute Arthritis, Scandinavian Journal of Rheumatology, vol.161, issue.2, pp.68-72, 1994.
DOI : 10.1136/ard.51.1.91

J. Balblanc, T. Conrozier, P. Mathieu, A. Tron, P. Broquet et al., Serum phospholipase A2 activity in osteoarthritis, Rev Rhum Ed Fr, vol.61, pp.311-318, 1994.

D. Schrier, C. Flory, M. Finkel, S. Kuchera, M. Lesh et al., The effects of the phospholipase A2 inhibitor manolide on cartilage degradation, stromelysin expression and synovial fluid cell count induced by intraarticular injection of human recombinant interleukin-1-in the rabbit, Arthritis Rheum, vol.39, pp.1291-1300, 1996.

M. Richard, E. Vignon, M. Peschard, P. Broquet, J. Carret et al., Serotonin-stimulated phospholipase A2 and collagenase activation in chondrocytes from human osteoarthritic articular cartilage, Febs Letters, vol.278, pp.38-40, 1991.

D. Taskiran, M. Stefanovic-racic, H. Georgescu, and C. Evans, Nitric-Oxide Mediates Suppression of Cartilage Proteoglycan Synthesis by Interleukin-1, Biochemical and Biophysical Research Communications, vol.200, issue.1, pp.142-150, 1994.
DOI : 10.1006/bbrc.1994.1426

E. Arner and M. Pratta, Modulation of interleukin-1???induced alterations in cartilage proteoglycan metabolism by activation of protein kinase C, Arthritis & Rheumatism, vol.164, issue.8, pp.1006-1019, 1991.
DOI : 10.1042/bj1800403

I. Setnikar, R. Palumbo, S. Canali, and G. Zanolo, Pharmacokinetics of glucosamine in man, Arzneim-Forsch, vol.3, pp.538-50, 1993.